<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2604-1227</journal-id>
<journal-title><![CDATA[Revista mexicana de oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. oftalmol]]></abbrev-journal-title>
<issn>2604-1227</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Oftalmología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2604-12272024000100003</article-id>
<article-id pub-id-type="doi">10.24875/rmo.m25000267</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Cirugía de catarata por vasculatura fetal persistente asociada con inyección de anti-VEGF: un nuevo enfoque]]></article-title>
<article-title xml:lang="en"><![CDATA[Persistent fetal vasculature cataract surgery associated with anti-VEGF injection: a new approach]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[Ana P. Silverio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Denadai]]></surname>
<given-names><![CDATA[Lucas]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Novaes]]></surname>
<given-names><![CDATA[Frederico do-Carmo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Moraes]]></surname>
<given-names><![CDATA[Nilva S. B.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Federal University of São Paulo Escola Paulista de Medicina Pediatric Cataract Service]]></institution>
<addr-line><![CDATA[São Paulo ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Federal University of São Paulo Escola Paulista de Medicina Retina and Vitreous Division]]></institution>
<addr-line><![CDATA[São Paulo ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Federal University of São Paulo Escola Paulista de Medicina Department of Ophthalmology and Visual Sciences]]></institution>
<addr-line><![CDATA[São Paulo ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Federal University of São Paulo Escola Paulista de Medicina Retina and Vitreous Division]]></institution>
<addr-line><![CDATA[São Paulo ]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2024</year>
</pub-date>
<volume>98</volume>
<numero>1</numero>
<fpage>17</fpage>
<lpage>19</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2604-12272024000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2604-12272024000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2604-12272024000100003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Presentamos un caso de inyección de anti-VEGF para prevenir el sangrado intraocular durante la cirugía. Parte del desarrollo del ojo humano incluye la formación y regresión de la red vascular que lo abastece. La vasculatura fetal persistente (VFP) es un trastorno congénito asociado a la falla en la regresión parcial o completa de la vasculatura hialoidea embrionaria. El remanente vascular conecta el disco óptico posteriormente con las estructuras oculares anteriores.  Observaciones: Los niños afectados pueden desarrollar catarata y otros hallazgos oculares. La extracción del cristalino, con o sin implantación de lente intraocular (LIO), es esencial para despejar el eje visual obstruido y prevenir la ambliopía. La lensectomía disminuye el riesgo de glaucoma secundario. La eliminación del tallo hialoideo libera la tracción sobre la retina y el cuerpo ciliar, reduciendo las posibilidades de restricción del crecimiento ocular, hipotonía o ptisis bulbi.  Conclusión: Clásicamente, se puede utilizar la endodiatermia para controlar o prevenir el sangrado de la VFP anterior y posterior; sin embargo, el sangrado intraocular sigue siendo una complicación frecuente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: We report a case of anti-vascular endothelial growth factor (VEGF) injection to prevent intraocular bleeding during surgery. Part of the development of the human eye is the formation and regression of the vascular network supply. Persistent fetal vasculature (PFV) is a congenital disorder associated with embryonic hyaloid vasculature failure to partially or comple- tely regress. The vascular remnant connects between the optic disc posteriorly to the anterior ocular structures.  Observations: Affected children may develop cataracts and several other ocular findings. Lens extraction with or without intraocular lens implantation is essential to clear the obstructed visual axis and to prevent amblyopia. Lensectomy lows the risk of secondary glaucoma. The removal of the hyaloid stalk releases retinal and ciliary body traction, reducing the chances of eye growth restriction, hypotony, or phthisis bulbi.  Conclusion: Classically, endodiathermy can be used to control or prevent bleeding from the anterior and posterior PFV, however intraocular bleeding is still a common complication.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Retina]]></kwd>
<kwd lng="es"><![CDATA[Aanti-VEGF]]></kwd>
<kwd lng="es"><![CDATA[Casculatura fetal persistente]]></kwd>
<kwd lng="es"><![CDATA[Catarata]]></kwd>
<kwd lng="es"><![CDATA[Congénito]]></kwd>
<kwd lng="en"><![CDATA[Retina]]></kwd>
<kwd lng="en"><![CDATA[Anti-vascular endothelial growth factor]]></kwd>
<kwd lng="en"><![CDATA[Persistent fetal vasculature]]></kwd>
<kwd lng="en"><![CDATA[Cataract]]></kwd>
<kwd lng="en"><![CDATA[Congenital]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zahavi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Weinberger]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Snir]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ron]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of severe persis- tent fetal vasculature:case series and review of the literature]]></article-title>
<source><![CDATA[Int Oph- thalmol]]></source>
<year>2019</year>
<volume>39</volume>
<page-range>579-87</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Xiao]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ding]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Persistent fetal vasculature]]></article-title>
<source><![CDATA[Asia Pac J Oph- thalmol (Phila)]]></source>
<year>2019</year>
<volume>8</volume>
<page-range>86-95</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prakhunhungsit]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Berrocal]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic and management strategies in patients with persistent fetal vasculature:current insights]]></article-title>
<source><![CDATA[Clin Oph- thalmol]]></source>
<year>2020</year>
<volume>14</volume>
<page-range>4325-35</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Belin]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Greaves]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kosoy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lieberman]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of bevacizumab in pediatric retinal and choroidal disease:a review]]></article-title>
<source><![CDATA[Eur J Ophthalmol]]></source>
<year>2019</year>
<volume>29</volume>
<page-range>338-47</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sankar]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sankar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chandra]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity]]></article-title>
<source><![CDATA[Cochrane Data- base Syst Rev]]></source>
<year>2018</year>
<volume>1</volume>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lyu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Fei]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intravitreal ranibizumab treatment for advanced familial exudative vitreoretinopathy with high vascular activity]]></article-title>
<source><![CDATA[Retina]]></source>
<year>2021</year>
<volume>41</volume>
<page-range>1976-85</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recent advances in the diagnosis and treatment of Coats'disease]]></article-title>
<source><![CDATA[Int Ophthalmol]]></source>
<year>2019</year>
<volume>39</volume>
<page-range>957-70</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
